Back to homepage

Tag "Amgen’s Neulasta drug"

FDA knocks back Novartis copy of Amgen’s drug Neulasta

FDA knocks back Novartis copy of Amgen’s drug Neulasta

🕔20:53, 19.Jul 2016

WASHINGTON: U.S. regulators have declined to approve Novartis’ so-called biosimilar copy of Amgen’s Neulasta drug that fights infections in cancer patients, the Swiss drugmaker said on Tuesday.

Read Full Article

Advertisement

Poll

Do you think prime minister's UN speech on Kashmir was up to the mark?

Advertisement

ARCHIVE

September 2016
M T W T F S S
« Aug    
 1234
567891011
12131415161718
19202122232425
2627282930